Author: HealDMD
-
Insmed’s INS1201: A New Gene Therapy Approach That Could Change the Game for DMD
A groundbreaking intrathecal gene therapy from Insmed is now in Phase I clinical trials. Here’s what DMD families need to know about INS1201 and the ASCEND study.